From owner-man-jp@jp.FreeBSD.org Tue Dec 21 15:01:39 2004
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id iBL61dS19473;
	Tue, 21 Dec 2004 15:01:39 +0900 (JST)
	(envelope-from owner-man-jp@jp.FreeBSD.org)
Received: from mail.com (modemcable190.199-70-69.mc.videotron.ca [69.70.199.190])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id iBL61c819444
	for <man-jp@jp.freebsd.org>; Tue, 21 Dec 2004 15:01:38 +0900 (JST)
	(envelope-from pltags@mail.com)
Received: from mail.com (mail-com-bk.mr.outblaze.com [205.158.62.24])
	by mail.com with esmtp
	id E2F5A2F6A7 for <man-jp@jp.freebsd.org>; Tue, 21 Dec 2004 08:00:00 +0100
From: "Eclecticism I. Disregard" <pltags@mail.com>
To: Man <man-jp@jp.FreeBSD.org>
Message-ID: <000001c4e72a$83369268$120309b5@mail.com>
MIME-Version: 1.0
Content-Type: text/plain
Content-Transfer-Encoding: 7bit
X-Priority: 3 (Normal)
X-MSMail-Priority: Normal
X-Mailer: Microsoft Outlook, Build 10.0.2605
Importance: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1165
X-Virus-Scanned: by amavisd-milter (http://amavis.org/)
Reply-To: man-jp@jp.FreeBSD.org
Precedence: list
Date: Tue, 21 Dec 2004 08:00:00 +0100
X-Sequence: man-jp 5687
Subject: [man-jp 5687] Man check out the money everyone has made in 10 days...
Sender: owner-man-jp@jp.FreeBSD.org
X-Originator: pltags@mail.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+041128

INVESTMENT ALERT 
EMERGING BIOTECH COMPANY SOON TO RELEASE GROUND BREAKING MEDICAL DEVICE 

In Vivo Medical Diagnostics, Inc (Stock Symbol OTC: IVVO) is finalizing its first ground-breaking portable medical device, the Prothrombin Time Monitor, that measures changes in the magnetic fields of blood on a molecular level. This is critical for patients undergoing anticoagulation therapy after heart attacks and strokes.
This measurement is now portable and is used in real time to achieve optimal medication levels, which is essential for successful treatment. IVVO has recently announced their joint effort with Inverness Medical Innovations a leading manufacturer and marketer of rapid diagnostic products in order to complete development of the Prothrombin Time Monitor for its clinical trials.
Prothrombin Testing is a massive market and continues to grow with projections in excess of $150 million in 2005 and over $500 million by 2010. IVVO is poised to capitalize on this significant opportunity. Dont miss out on the near term upside potential in IVVO! 

INVESTMENT ANAYSIS 

In Vivo Medical Diagnostics, Inc. (Stock Symbol OTC: IVVO)
Short-Term Target: $3.00
12-Month Target: $5.00
Recommendations: Very Strong Buy
Long Term Outlook: Excellent 

Heart disease is the most common cause of death and cardiovascular disease affects over 60 million people worldwide. The largest area of growth in the Health Care Sector is in Patient Management. This growth is caused by patients with chronic conditions, who are forced to make frequent and costly hospital visits to monitor their condition. 

In Vivo Medical Diagnostics utilizes the Hall effect, which is a well-known physics phenomenon that can be used to measure changes in magnetic fields at the molecular level. IVVO has taken this proven science and has used it for imaging purposes which is applied to many different applications, including the cardiovascular and diabetes markets .

IVVO is a well-established company that has been operating for over eight years. IVVO currently has two additional products in their 2nd clinical trials, a pregnancy labor monitor and a fetal heart rate monitor, along with 12 Patents that will allow them to extend their technology to other emerging medical solutions. IVVO is currently profitable with additional royalty income beginning in 2005. IVVO has sufficient funds on hand to take them well into 2006. 

Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements. Please be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned herein. This newsletter is neither a registered investment advisor nor affiliated with any broker or dealer. This newsletter is not affiliated with In Vivo Medical Diagnostics, Inc in any way. This newsletter was produced and distributed by a independent third party. All statements made are our express opinion only and should be treated as such. We may own, buy and sell any securities mentioned at any time. This report includes forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements may include terms as "expect", "believe", "may", "will", "move","undervalued" and "intend" or similar terms. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You may lose money from investing in Penny Stocks.








Desperate diseases must have desperate remedies. . Sound as a bell. . Heavy givers are light complainers. . One today is worth two tomorrows. .  
Nothing dries sooner than a tear.   
  
Everything has an end.   

Persuasion is better than force. . Absence makes the fond heart wander. . It's an ill bird that fouls its own nest. . Once a task has first begun, never quit until it's done,.  
Putting the cart before the horse.   
  
We cannot erase the sad records from our past. . Putting the cart before the horse.  Sauce for the goose is sauce for the gander. .


